Literature DB >> 16893656

Tumor and viral recognition by natural killer cells receptors.

Tal I Arnon1, Gal Markel, Ofer Mandelboim.   

Abstract

Natural killer (NK) cells destroy hazardous cells such as tumors and virus-infected cells immediately without the need for prior antigen stimulation. The activation of NK cells largely depends on the recently identified natural cytotoxic receptors (NCRs), which include three members: NKp46, NKp44 and NKp30. The NCRs are unique in their expression pattern that is almost conclusively confined to NK cells, and in their broad specificity towards a wide range of targets. However, very little is known about the ligands identity of the NCRs and so far the only ligands known are two virally derived molecules: the hemagglutinin protein of influenza viruses that directly binds and activates two of the NCRs; NKp46 and NKp44, and the human cytomegalovirus tegument protein, pp65, which binds the NKp30 receptor and inhibits its activation thus promoting survival of the virus. In this review we describe the function of the NCRs in various pathological conditions with a special emphasis on tumor targeting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893656     DOI: 10.1016/j.semcancer.2006.07.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  65 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

Review 3.  Immune evasion of natural killer cells by viruses.

Authors:  Stipan Jonjić; Marina Babić; Bojan Polić; Astrid Krmpotić
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

4.  Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins.

Authors:  Hagit Achdout; Irit Manaster; Ofer Mandelboim
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

5.  Cell-type-specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46.

Authors:  George Zahariadis; Melany J Wagner; Rosalyn C Doepker; Jessica M Maciejko; Carly M Crider; Keith R Jerome; James R Smiley
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

Review 6.  Natural killer cells and regulatory T cells in early pregnancy loss.

Authors:  Surendra Sharma
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

7.  NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Authors:  Yotam Bar-On; Yoav Charpak-Amikam; Ariella Glasner; Batya Isaacson; Alexandra Duev-Cohen; Pinchas Tsukerman; Alexander Varvak; Michal Mandelboim; Ofer Mandelboim
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

8.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

9.  Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.

Authors:  Olivier Morteau; Samkeliso Blundell; Aron Chakera; Sophia Bennett; Charita M Christou; Philip D Mason; Richard J Cornall; Christopher A O'Callaghan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

10.  Anti-West Nile virus activity of in vitro expanded human primary natural killer cells.

Authors:  Mingjie Zhang; Sylvester Daniel; Yong Huang; Caren Chancey; Qingsheng Huang; Ying F Lei; Andriyan Grinev; Howard Mostowski; Maria Rios; Andrew Dayton
Journal:  BMC Immunol       Date:  2010-01-20       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.